1. Home
  2. PTGX vs UTG Comparison

PTGX vs UTG Comparison

Compare PTGX & UTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • UTG
  • Stock Information
  • Founded
  • PTGX 2006
  • UTG 2003
  • Country
  • PTGX United States
  • UTG United States
  • Employees
  • PTGX N/A
  • UTG N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • UTG Investment Managers
  • Sector
  • PTGX Health Care
  • UTG Finance
  • Exchange
  • PTGX Nasdaq
  • UTG Nasdaq
  • Market Cap
  • PTGX 4.0B
  • UTG 3.3B
  • IPO Year
  • PTGX 2016
  • UTG N/A
  • Fundamental
  • Price
  • PTGX $78.62
  • UTG $38.22
  • Analyst Decision
  • PTGX Strong Buy
  • UTG
  • Analyst Count
  • PTGX 9
  • UTG 0
  • Target Price
  • PTGX $78.11
  • UTG N/A
  • AVG Volume (30 Days)
  • PTGX 1.6M
  • UTG 317.8K
  • Earning Date
  • PTGX 10-31-2025
  • UTG 01-01-0001
  • Dividend Yield
  • PTGX N/A
  • UTG 7.28%
  • EPS Growth
  • PTGX N/A
  • UTG N/A
  • EPS
  • PTGX 0.80
  • UTG 9.86
  • Revenue
  • PTGX $209,180,000.00
  • UTG $96,107,593.00
  • Revenue This Year
  • PTGX N/A
  • UTG N/A
  • Revenue Next Year
  • PTGX $142.86
  • UTG N/A
  • P/E Ratio
  • PTGX $97.73
  • UTG $3.20
  • Revenue Growth
  • PTGX N/A
  • UTG 8.35
  • 52 Week Low
  • PTGX $33.31
  • UTG $25.26
  • 52 Week High
  • PTGX $93.25
  • UTG $35.29
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 61.88
  • UTG 43.06
  • Support Level
  • PTGX $73.08
  • UTG $38.00
  • Resistance Level
  • PTGX $79.00
  • UTG $38.62
  • Average True Range (ATR)
  • PTGX 2.39
  • UTG 0.83
  • MACD
  • PTGX -0.24
  • UTG -0.22
  • Stochastic Oscillator
  • PTGX 93.42
  • UTG 23.85

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About UTG Reaves Utility Income Fund of Beneficial Interest

Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.

Share on Social Networks: